tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
Advertisement

Janux Therapeutics Inc (JANX) Ownership - Who Owns Janux Therapeutics Inc?

Compare
474 Followers

Janux Therapeutics Inc (JANX) Ownership Overview

48.35%21.43%0.10%9.20%20.92%
48.35% Insiders
0.10% Other Institutional Investors
9.20% ETFs
20.92% Public Companies and
Individual Investors
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 30.73% of the company’s stock is owned by Institutional Investors, 48.35% is owned by Insiders, and 20.92% is owned by Public Companies and Individual Investors.
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 21.53% of the company’s stock is owned by Institutional Investors, 48.35% is owned by Insiders, and 9.20% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 07, 2025
xxxxxxxxxxxxx
$25342965
Oct 24, 2024
xxxxxxxxxxxxx
$178084
Oct 22, 2024
xxxxxxxxxxxxx
$53700000
Oct 18, 2024
xxxxxxxxxxxxx
$77472371

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$24208
Jun 30, 2025
xxxxxxxxxxxxx
$151097
Jun 30, 2025
xxxxxxxxxxxxx
$1048994
Jun 30, 2025
xxxxxxxxxxxxx
$6761046

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,195,943Insider18.63%269,262,429
11,189,693Institution18.62%269,112,117
7,377,765Insider12.28%177,435,248
6,560,816Insider10.92%157,787,625
2,644,622Insider4.80%63,603,159
2,440,594Institution4.06%58,696,286
2,068,630Institution3.44%49,750,552
1,879,748Institution3.13%45,207,939
1,713,775Institution2.85%41,216,289
1,305,694Institution2.17%31,401,941

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,440,594Institution4.06%58,696,286
1,713,775Institution2.85%41,216,289
1,305,694Institution2.17%31,401,941
1,286,199Institution2.14%30,933,086
1,071,689Institution1.78%25,774,120
778,489Institution1.30%18,722,660
609,989Institution1.02%14,670,235
445,252Institution0.74%10,708,311
372,178Institution0.62%8,950,881
365,057Institution0.61%8,779,621

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,175,973Institution1.96%28,240,992
972,192Institution1.62%23,381,218
592,324Institution0.99%14,879,179
356,113Institution0.59%8,552,054
300,645Institution0.50%7,230,512
234,681Institution0.39%5,644,078
187,683Institution0.31%4,507,207
156,670Institution0.26%3,935,550
127,478Institution0.21%3,061,384
123,491Institution0.21%3,102,094

FAQ

Who Owns Janux Therapeutics Inc (JANX)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 48.35% is held by insiders, and 20.92% is held by retail investors.
    What percentage of Janux Therapeutics Inc (JANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.10% of Janux Therapeutics Inc (JANX) stock is held by institutional investors.
      What percentage of Janux Therapeutics Inc (JANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.92% of Janux Therapeutics Inc (JANX) stock is held by retail investors.
        Who owns the most shares of Janux Therapeutics Inc (JANX)?
        Ra Capital Management, Llc owns the most shares of Janux Therapeutics Inc (JANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis